For confirmation, FLT3-ITD;NPMc or iMLL-AF9 AML blasts treated with an FLT3 inhibitor (AC220) or Ara-C, respectively, were cultured alone or with BMSCs. This evidence concerns the gene FLT3 and acute myeloid leukemia.